상단으로
Choose your location
Select your country or region to view content specific to your country.
Seegene’s targeting of Canadian medical market started in earnest with appointing the New president of Canadian subsidiary
Jan 05, 2016
?
Having founded its Canadian subsidiary (Seegene Canada Inc.) in 2015 to tap into and expand its Canadian market, Seegene recently presented Seegene Canada President James Yantzi with an official letter of appointment during his visit to Seegene’s Seoul headquarters. The appointment represents a step forward for business plans and strategy development of Canadian market for 2016. Mr. Yantzi has extensive experience in the medical device and diagnostics markets, and he has been in charge of sales and marketing for Seegene’s products in the Canadian medical market since 2008.?
?
Seegene successfully entered the Canadian medical market with its respiratory disease and sexually transmitted infections (STIs) detection products that have certified by Health Canada as in vitro diagnostic agents. Especially, Seegene respiratory disease detection product received outstanding performance evaluation in Canada, it has resulted to attract large customer base on the respiratory virus screening market.
?
Through Seegene Canada, Seegene will be able to more aggressively expand its sales of molecular diagnostic product and the automated diagnostic solution. This new changes especially will be ramped up Seegene’s sales at Commercial labs with marketing efforts which had many hurdles to get in to the market due to various factors (e.g. price competition).
?
In addition to the respiratory infections detection product and STIs detection product which has been obtained certification from Health Canada, Seegene will be working to obtain its other detection products including HPV and gastrointestinal infectious disease (e.g. diarrhea) as well. This will be yet another step forward in pioneering new markets and finding potential customers.
?
Seegene Canada President Yantzi stated, “The demand for molecular diagnosis in the Canadian medical market is increasing faster than in any other country in the world.” He revealed his ambitions for Seegene Canada as “overcoming the limitations of the existing business capability of stores by turning them into local subsidiaries and focusing on targeting a medical market that is based on private and Canadian government-operated commercial lab. In this way, Seegene can continuously expand its market share in Canada.